Realcan Pharmaceutical Group Co., Ltd. (SHE:002589)

China · Delayed Price · Currency is CNY

3.220

+0.080 (2.55%)

At close: Mar 6, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Drugs and Devices	7.87B	7.96B	12.21B	20.95B	27.13B
Drugs and Devices Growth	-1.04%	-34.84%	-41.72%	-22.76%	-22.88%
Mobile health	68.41M	52.34M	77.20M	86.88M	75.23M
Mobile health Growth	30.70%	-32.21%	-11.13%	15.48%	-7.77%
Lease	24.13M	25.42M	22.72M	19.14M	30.03M
Lease Growth	-5.06%	11.89%	18.72%	-36.27%	-
Total	7.97B	8.03B	12.31B	21.06B	27.23B
Total Growth	-0.85%	-34.74%	-41.54%	-22.67%	-22.76%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
China	7.97B	8.03B	12.31B	21.06B	27.23B
China Growth	-0.85%	-34.74%	-41.54%	-22.67%	-22.76%
Total	7.97B	8.03B	12.31B	21.06B	27.23B
Total Growth	-0.85%	-34.74%	-41.54%	-22.67%	-22.76%

Source: S&P Global Market Intelligence.